Welcome to our dedicated page for Broadway Finl Del SEC filings (Ticker: BYFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Broadway Financial Corporation (NASDAQ: BYFC) SEC filings page on Stock Titan provides access to the company’s regulatory reports as filed with the U.S. Securities and Exchange Commission. As a savings and loan holding company and parent of City First Bank, National Association, Broadway Financial Corporation uses these filings to disclose detailed information about its financial condition, results of operations, risk profile, and governance.
Investors can review Broadway Financial Corporation’s annual and quarterly reports, such as Forms 10-K and 10-Q, which include information on net interest income, net interest margin, loan and deposit balances, credit quality metrics, allowance for credit losses, and non-interest income and expenses. These filings also describe how the bank’s lending and deposit activities support affordable housing, small businesses, and nonprofit community facilities in low-to-moderate income neighborhoods, as disclosed in the company’s public materials.
Recent 8-K filings highlight several important developments. The company has reported Nasdaq notices related to non-compliance with Listing Rule 5250(c)(1) due to delays in filing certain Quarterly Reports on Form 10-Q, and has described plans and extensions to regain compliance. Broadway Financial Corporation has also filed 8-K reports stating that its Audit Committee concluded goodwill is impaired, leading to an expected non-cash goodwill impairment charge, and that certain previously issued financial statements should no longer be relied upon because of an error in accounting for loan participation agreements under Accounting Standards Codification Topic 860. The company has indicated that these financial statements will be restated and that a material weakness in internal control over financial reporting was identified.
On Stock Titan, BYFC filings are updated as new documents are posted to the SEC’s EDGAR system. AI-powered summaries help explain the key points of complex filings, including 8-K current reports on material events, and highlight how accounting changes, restatements, and compliance matters may affect the company’s reported results. Users can also review disclosures related to internal control over financial reporting, goodwill impairment, and other topics that appear in Broadway Financial Corporation’s SEC reports.
Broadway Financial Corporation reports a loan-focused balance sheet centered on mission-driven multifamily and commercial real estate lending. At December 31, 2025, total loans held for investment were $1.02 billion, with multifamily loans of $593.2 million and commercial real estate loans of $162.6 million.
Adjustable-rate structures dominate, with more than 82% of loans carrying adjustable features. Asset quality weakened from a very strong base as non‑performing assets rose to $11.2 million, or 1.09% of gross loans, while the allowance for credit losses increased to $9.4 million, or 0.92% of gross loans.
Broadway also holds an available‑for‑sale securities portfolio of $256.8 million, representing 19.1% of total assets. Funding comes primarily from $718.5 million in average deposits during 2025 and $72.0 million of year‑end FHLB advances, complemented by $80.8 million in securities sold under repurchase agreements. The bank remains strongly capitalized with a Community Bank Leverage Ratio of 14.09%, well above the 9% “well capitalized” threshold.
The Vanguard Group filed an Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of Broadway Financial Corp common stock as 0 shares representing 0%.
The filing explains an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries report holdings separately and Vanguard Inc. no longer is deemed to beneficially own those securities.
Driver John reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director John Driver received an award of 2,675 shares of common stock on March 2, 2026. The unrestricted stock was issued under the company’s amended and restated 2018 Long Term Incentive Plan at a reported price of $7.85 per share, bringing his direct holdings to 9,211 shares.
Donovan Mary Ann reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp director Mary Ann Donovan reported an equity award of common stock. She received 2,675 shares on March 2, 2026 at a reference price of $7.85 per share, issued as unrestricted stock under the Amended and Restated 2018 Long Term Incentive Plan. Following this grant, her direct holdings increased to 10,223 common shares, reflecting amounts already adjusted for a reverse stock split effective October 31, 2023.
Broadway Financial Corporation reported that EVP and Chief Credit Officer LaShanya Demetrice Washington acquired 6,480 shares of common stock as a restricted stock grant on March 2, 2026, at $7.85 per share. The award vests over four years under the company’s 2018 Long-Term Incentive Plan, bringing her direct holdings to 22,300 shares.
JOHNS MARIE C reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corporation director Marie C. Johns received an equity award of 2,675 shares of Common Stock on March 2, 2026. The award was granted at a price of $7.85 per share under the company’s amended and Restated 2018 Long Term Incentive Plan. Following this grant, Johns directly owns 10,223 shares of Broadway Financial common stock. A footnote explains that prior amounts were adjusted to reflect a reverse stock split effective October 31, 2023.
McGrady David J. reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. director David J. McGrady reported receiving an award of 2,675 shares of common stock on March 2, 2026. The unrestricted stock was granted under the company’s amended and Restated 2018 Long Term Incentive Plan, bringing his directly held stake to 10,223 shares.
Argrett Brian E reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. reported that President and CEO Brian E. Argrett was granted 23,793 shares of restricted common stock on March 2, 2026 at a reference price of $7.85 per share. Following this equity award, his directly held common stock position increased to 125,752 shares.
The restricted stock will vest over time, with 33% of the shares vesting on the first anniversary of the grant date and the remaining balance vesting ratably over the next 24 months. The filing also notes that the share amounts have been adjusted to reflect a reverse stock split effective October 31, 2023.
Bradshaw Wayne-Kent A. reported acquisition or exercise transactions in this Form 4 filing.
Broadway Financial Corp. director Wayne-Kent A. Bradshaw received an award of 2,675 shares of common stock on March 2, 2026. The shares were issued as unrestricted stock under the company’s Amended and Restated 2018 Long Term Incentive Plan.
After this grant, Bradshaw directly owns a total of 43,359 common shares, which includes 5,216 shares allocated under the ESOP and reflects adjustments for a reverse stock split effective October 31, 2023.
Broadway Financial Corporation executive William Justin Jennings reported an equity grant. He acquired 4,458 shares of common stock on March 2, 2026 as a grant or award valued at $7.85 per share. These are restricted shares that vest over four years under the company’s Amended and Restated 2018 Long-Term Incentive Plan. After this grant, he directly holds 9,394 common shares.